![John Jenkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Jenkins
Director/Board Member at
CORBUS PHARMACEUTICALS HOLDINGS, INC.
Net worth: - $ as of 31/05/2026
Profile
John Kenneth Jenkins is currently Director at Corbus Pharmaceuticals, Inc., Independent Director at Corbus Pharmaceuticals Holdings, Inc. since 2018, and Principal-Drug & Biological Products at Greenleaf Health Inc. since 2019.
Former positions include Director-Acting Division at US Food & Drug Administration from 1992 to 2002, Director-New Drugs at Center for Drug Evaluation & Research from 2002 to 2017, Independent Director at Provention Bio, Inc. from 2020 to 2023, and Assistant Professor at Virginia Commonwealth University Health System.
Education includes a doctorate from the University of Tennessee.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
John Jenkins active positions
| Companies | Position | Start |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 05/06/2018 |
Greenleaf Health Inc.
 Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Provides FDA regulatory consulting services | Corporate Officer/Principal | 01/02/2019 |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Board Member | - |
Former positions of John Jenkins
| Companies | Position | End |
|---|---|---|
| PROVENTION BIO, INC. | Director/Board Member | 27/04/2023 |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Corporate Officer/Principal | 01/01/2017 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2002 |
Virginia Commonwealth University Health System
 Virginia Commonwealth University Health System Miscellaneous Commercial ServicesCommercial Services Provides clinical research services for cancer treatment | Corporate Officer/Principal | - |
Training of John Jenkins
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
38
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Virginia Commonwealth University Health System
Virginia Commonwealth University Health System Miscellaneous Commercial ServicesCommercial Services Provides clinical research services for cancer treatment | Commercial Services |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Greenleaf Health Inc.
Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Provides FDA regulatory consulting services | Commercial Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
- Stock Market
- Insiders
- John Jenkins
